The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26

被引:52
|
作者
Varasteh, Zohreh [1 ]
Mitran, Bogdan [1 ]
Rosenstrom, Ulrika [3 ]
Velikyan, Irina [1 ]
Rosestedt, Maria [1 ]
Lindeberg, Gunnar [3 ]
Sorensen, Jens [4 ]
Larhed, Mats [5 ]
Tolmachev, Vladimir [2 ]
Orlova, Anna [1 ]
机构
[1] Uppsala Univ, Fac Pharm, Dept Med Chem, Preclin PET Platform, S-75183 Uppsala, Sweden
[2] Uppsala Univ, Fac Med, Dept Immunol Genet & Pathol, S-75183 Uppsala, Sweden
[3] Uppsala Univ, Fac Pharm, Dept Med Chem, Organ Pharmaceut Chem, S-75183 Uppsala, Sweden
[4] Uppsala Univ, Nucl Med & PET, S-75183 Uppsala, Sweden
[5] Uppsala Univ, Fac Pharm, Dept Med Chem, Sci Life Lab, S-75183 Uppsala, Sweden
基金
瑞典研究理事会;
关键词
Bombesin antagonistic analog; NOTA; DOTA; NODAGA; DOTAGA; Molecular imaging; CONJUGATED BOMBESIN ANTAGONIST; POSITRON-EMISSION-TOMOGRAPHY; PET; EXPRESSION; CONSTANTS; AFFINITY; AGONISTS; BINDING; CANCER; LENGTH;
D O I
10.1016/j.nucmedbio.2014.12.009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: Overexpression of gastrin-releasing peptide receptors (GRPR) has been reported in several cancers. Bombesin (BN) analogs are short peptides with a high affinity for GRPR. Different BN analogs were evaluated for radionuclide imaging and therapy of GRPR-expressing tumors. We have previously investigated an antagonistic analog of BN (D-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH2, RM26) conjugated to NOTA via a PEG(2) spacer (NOTA-PEG(2)-RM26) labeled with Ga-68, In-111 and (AlF)-F-18. Ga-68-labeled NOTA-PEG(2)-RM26 showed high tumor-to-organ ratios. Methods: The influence of different macrocyclic chelators (NOTA, NODAGA, DOTA and DOTAGA) on the targeting properties of Ga-68-labeled PEG(2)-RM26 was studied in vitro and in vivo. Results: All conjugates were labeled with generator-produced Ga-68 with high yields and demonstrated high stability and specific binding to GRPR. The IC50 values of Ga-nat-X-PEG(2)-RM26 (X = NOTA, DOTA, NODAGA, DOTAGA) were 2.3 +/- 0.2, 3.0 +/- 0.3, 2.9 +/- 0.3 and 10.0 +/- 0.6 nM, respectively. The internalization of the conjugates by PC-3 cells was low. However, the DOTA-conjugated analog demonstrated a higher internalization rate compared to other analogs. GRPR-specific uptake was found in receptor-positive normal tissues and PC-3 xenografts for all conjugates. The biodistribution of the conjugates was influenced by the choice of the chelator moiety. Although all radiotracers cleared rapidly from the blood, [Ga-68]Ga-NOTA-PEG(2)-RM26 showed significantly lower uptake in lung, muscle and bone compared to the other analogs. The uptake in tumors (5.40 +/- 1.04 %ID/g at 2 h p.i.) and the tumor-to-organ ratios (25 +/- 3, 157 +/- 23 and 39 +/- 4 for blood, muscle and bone, respectively) were significantly higher for the NOTA-conjugate than the other analogs. Conclusions: Chelators had a clear influence on the biodistribution and targeting properties of Ga-68-labeled antagonistic BN analogs. Positively charged [Ga-68]Ga-NOTA-PEG(2)-RM26 provided a low kidney radioactivity uptake, high affinity, high tumor uptake and high image contrast. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:446 / 454
页数:9
相关论文
共 50 条
  • [21] Synthesis and preclinical evaluation of gastrin releasing peptide receptor antagonist [18F]MeTz-PEG2-RM26 for positron emission tomography
    Panagiotis Kanellopoulos
    Fanny Lundmark
    Ayman Abouzayed
    Lorenzo Jacopo Ilic Balestri
    Esther Olaniran Håkansson
    Karim Obeid
    Luke R. Odell
    Vladimir Tolmachev
    Ulrika Rosenström
    Jonas Eriksson
    Anna Orlova
    EJNMMI Radiopharmacy and Chemistry, 10 (1)
  • [22] Preclinical Comparison of Al18F- and 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonists for PET Imaging of Prostate Cancer
    Chatalic, Kristell L. S.
    Franssen, Gerben M.
    van Weerden, Wytske M.
    McBride, William J.
    Laverman, Peter
    de Blois, Erik
    Hajjaj, Bouchra
    Brunel, Luc
    Goldenberg, David M.
    Fehrentz, Jean-Alain
    Martinez, Jean
    Boerman, Otto C.
    de Jong, Marion
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (12) : 2050 - 2056
  • [23] Evaluation of a Dual Integrin αvβ3 and Gastrin-Releasing Peptide Receptor Targeting PET tracer [68Ga]Ga-RM26-RGD in Breast Cancer Patients
    Wang, R.
    Wen, X.
    Xu, P.
    Zhang, X.
    Guo, Z.
    Zhu, Z.
    Chen, X.
    Zhang, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S263 - S263
  • [24] Evaluation of mercaptoacetyl-based amino acid containing chelators for labeling of GRPR antagonist PEG2-RM26 with 99mTc
    Sabahnoo, H.
    Abouzayed, A.
    Rinne, S.
    Tolmachev, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S674 - S674
  • [25] 68Ga-radiolabeling and pharmacological characterization of a kit-based formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) antagonist RM2 for convenient preparation of [68Ga]Ga-RM2
    Morgat, C.
    Chastel, A.
    Vimont, D.
    Claverol, S.
    Berndt, M.
    Zerna, M.
    Chaignepain, S.
    Hindie, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S409 - S409
  • [26] 68Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [68Ga]Ga-RM2
    Chastel, Adrien
    Vimont, Delphine
    Claverol, Stephane
    Zerna, Marion
    Bodin, Sacha
    Berndt, Mathias
    Chaignepain, Stephane
    Hindie, Elif
    Morgat, Clement
    PHARMACEUTICS, 2021, 13 (08)
  • [27] Gastrin-Releasing Peptide Receptor Antagonist [68Ga]RM2 PET/CT for Staging of Pre-Treated, Metastasized Breast Cancer
    Michalski, Kerstin
    Kemna, Lars
    Asberger, Jasmin
    Grosu, Anca L.
    Meyer, Philipp T.
    Ruf, Juri
    Sprave, Tanja
    CANCERS, 2021, 13 (23)
  • [28] [68Ga]Ga-ProBOMB5-a novel 68Ga-labeled [Leu13IPro14]bombesin analog for imaging gastrin-releasing peptide receptor expression with positron emission tomography
    Wang, Lei
    Kuo, Hsiou-Ting
    Chapple, Devon
    Colpo, Nadine
    Zhang, Chengcheng
    Wilson, Ryan
    Benard, Francois
    Lin, Kuo-Shyan
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [29] Targeting of MMP2 activity in malignant tumors with a 68Ga-labeled gelatinase inhibitor cyclic peptide
    Liu, Qinghua
    Pan, Donghui
    Cheng, Chao
    Zhang, Anyu
    Ma, Chao
    Wang, Lizhen
    Zhang, Dazhi
    Liu, Hongrui
    Jiang, Hongdie
    Wang, Tao
    Xu, Yuping
    Yang, Runlin
    Chen, Fei
    Yang, Min
    Zuo, Changjing
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (12) : 939 - 944
  • [30] Synthesis, preclinical, and initial clinical evaluation of integrin αVβ3 and gastrin-releasing peptide receptor (GRPR) dual-targeting radiotracer [68Ga]Ga-RGD-RM26-03
    Wen, Xuejun
    Wang, Rongxi
    Xu, Pengfei
    Shi, Mengqi
    Shang, Qingyao
    Zeng, Xueyuan
    Zeng, Xinying
    Liu, Jia
    Wang, Xin
    Zhu, Zhaohui
    Guo, Zhide
    Chen, Xiaoyuan
    Zhang, Jingjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 (07) : 2023 - 2035